New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 5, 2014
06:54 EDTHALOHalozyme 7.69M share Secondary priced at $13.00
JPMorgan and Citigroup acted as joint book running managers for the offering.
News For HALO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
June 22, 2015
07:45 EDTHALOHalozyme price target raised to $25 from $20 at JPMorgan
JPMorgan raised its price target for Halozyme to $25 after speaking with CEO Hellen Torley. The firm remains positive on the potential for PEGPH20 and keeps an Overweight rating on the stock.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use